US09062W2044
US09062W2044
BioLife Solutions, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.89B EUR | -- | -- | -- |
Enterprise Value | 1.82B EUR | -- | -- | -- |
Valuation Multiples | ||||
Trailing P/E | 39x | -- | -- | -- |
Forward P/E | 117x | -- | -- | -- |
Price to Sales | 17.71x | -- | -- | -- |
Price to Book | 4.49x | -- | -- | -- |
EV/Revenue | 17.07x | -- | -- | -- |
EV/EBITDA | 264x | -- | -- | -- |
Price to FCF (P/FCF) | 404.93x | -- | -- | -- |
EV/FCF | 390.49x | -- | -- | -- |
FCF Yield | 0.25% | -- | -- | -- |